These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9051844)

  • 1. Evaluation of a novel lipid prodrug for intraocular drug delivery: effect of acyclovir diphosphate dimyristoylglycerol in a rabbit model with herpes simplex virus-1 retinitis.
    Taskintuna I; Banker AS; Flores-Aguilar M; Bergeron-Lynn G; Aldern KA; Hostetler KY; Freeman WR
    Retina; 1997; 17(1):57-64. PubMed ID: 9051844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral effect in human cytomegalovirus-infected cells, pharmacokinetics, and intravitreal toxicology in rabbits of acyclovir diphosphate dimyristoylglycerol.
    Shakiba S; Freeman WR; Flores-Aguilar M; Munguia D; Tatebayashi M; Besen G; Amani R; Wiley CA; Vuong C; Aldern KA
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1383-5. PubMed ID: 7574537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovir.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Toyoguchi M; Bergeron-Lynn G; Freeman WR
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):515-21. PubMed ID: 11818399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclovir diphosphate dimyristoylglycerol: a phospholipid prodrug with activity against acyclovir-resistant herpes simplex virus.
    Hostetler KY; Parker S; Sridhar CN; Martin MJ; Li JL; Stuhmiller LM; van Wijk GM; van den Bosch H; Gardner MF; Aldern KA
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11835-9. PubMed ID: 8265634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
    Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of herpes retinitis in an animal model with a sustained delivery antiviral drug, liposomal 1-O-octadecyl-SN-glycerol-3-phosphonoformate.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Ozerdem U; Bergeron-Lynn G; Mach-Hofacre B; Mueller AJ; Severson GM; Freeman WR
    Retina; 1999; 19(4):325-31. PubMed ID: 10458299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis.
    Kuppermann BD; Assil KK; Vuong C; Besen G; Wiley CA; De Clercq E; Bergeron-Lynn G; Connor JD; Pursley M; Munguia D; Freeman WR
    J Infect Dis; 1996 Jan; 173(1):18-23. PubMed ID: 8537656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term therapy for herpes retinitis in an animal model with high-concentrated liposome-encapsulated HPMPC.
    Besen G; Flores-Aguilar M; Assil KK; Kupperman BD; Gangan P; Pursley M; Munguia D; Vuong C; De Clercq E; Bergeron-Lynn G
    Arch Ophthalmol; 1995 May; 113(5):661-8. PubMed ID: 7748139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of viral retinitis.
    Schulman JA; Peyman GA
    Ophthalmic Surg; 1988 Dec; 19(12):876-84. PubMed ID: 2852786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.
    Flores-Aguilar M; Huang JS; Wiley CA; De Clercq E; Vuong C; Bergeron-Lynn G; Chandler B; Munguia D; Freeman WR
    J Infect Dis; 1994 Mar; 169(3):642-7. PubMed ID: 8158041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of oxetanocin G against herpes simplex virus type 2 and murine cytomegalovirus infections in mice.
    Nishiyama Y; Yamamoto N; Yamada Y; Fujioka H; Shimada N; Takahashi K
    J Antibiot (Tokyo); 1989 Aug; 42(8):1308-11. PubMed ID: 2547744
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of rapid selection for acyclovir or penciclovir resistance following suboptimal oral prodrug therapy of HSV-infected mice.
    Sarisky RT; Bartus HR; Dennis SA; Quail MR; Nguyen TT; Wittrock RJ; Halsey WS; Bacon TH; Leary JJ; Sutton D
    BMC Infect Dis; 2001; 1():24. PubMed ID: 11749671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity of famciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.
    Ashton RJ; Abbott KH; Smith GM; Sutton D
    J Antimicrob Chemother; 1994 Aug; 34(2):287-90. PubMed ID: 7814291
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravitreal injection of liposome-encapsulated ganciclovir in a rabbit model.
    Peyman GA; Khoobehi B; Tawakol M; Schulman JA; Mortada HA; Alkan H; Fiscella R
    Retina; 1987; 7(4):227-9. PubMed ID: 3501604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Famciclovir/penciclovir.
    Sacks SL; Wilson B
    Adv Exp Med Biol; 1999; 458():135-47. PubMed ID: 10549386
    [No Abstract]   [Full Text] [Related]  

  • 17. A rare presentation of an atypical herpes simplex virus retinitis in an immunocompetent patient following an episode of fever.
    Kumar A; Nair N; Sudharshan S; Malathy J; Biswas J
    Indian J Ophthalmol; 2020 Sep; 68(9):1953-1955. PubMed ID: 32823431
    [No Abstract]   [Full Text] [Related]  

  • 18. New prodrugs of acyclic nucleosides with antiviral activity.
    Winkelmann E; Winkler I; Rolly H; Rösner M; Jähne G
    Arzneimittelforschung; 1988 Nov; 38(11):1545-8. PubMed ID: 3265058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal antiviral injections as adjunctive therapy in the management of immunocompetent patients with necrotizing herpetic retinopathy.
    Luu KK; Scott IU; Chaudhry NA; Verm A; Davis JL
    Am J Ophthalmol; 2000 Jun; 129(6):811-3. PubMed ID: 10926999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of acute HSV-2 retinal necrosis.
    Tran TH; Stanescu D; Caspers-Velu L; Rozenberg F; Liesnard C; Gaudric A; Lehoang P; Bodaghi B
    Am J Ophthalmol; 2004 May; 137(5):872-9. PubMed ID: 15126152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.